BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1593677)

  • 1. Bladder tumor control by abdominal ultrasound and urine cytology.
    Berlac PA; Holm HH
    J Urol; 1992 Jun; 147(6):1510-2. PubMed ID: 1593677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].
    Cariou G; Maaraoui N; Cortesse A
    Prog Urol; 1997 Feb; 7(1):51-5. PubMed ID: 9116739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder tumour control by abdominal ultrasound and urine cytology.
    Juul N; Torp-Pedersen S; Larsen S; Rasmussen F; Holm HH
    Scand J Urol Nephrol; 1986; 20(4):275-8. PubMed ID: 3544204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Suprapubic bladder ultrasonography and urinary cytology: indications and limits in the follow-up of superficial bladder tumors].
    Pegoraro C; Bondavalli C; Molani L; Capitanio A; Schiavon L; Dall'Oglio B; Luciano M; Negri S
    Arch Ital Urol Nefrol Androl; 1991 Jun; 63 Suppl 2():127-9. PubMed ID: 1836650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urine cytology as a supplement to cystoscopy and biopsy in the control of bladder tumors].
    Andersen OP; Ladefoged C; Røhl HF; Osther P; Holm K
    Ugeskr Laeger; 1989 Dec; 151(50):3400-1. PubMed ID: 2609449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of selective upper tract cytology for recognition of upper tract tumors after treatment of superficial bladder cancer.
    Gögüs C; Baltaci S; Sahinli S; Türkölmez K; Bedük Y; Göğüs O
    Int J Urol; 2003 May; 10(5):243-6. PubMed ID: 12694462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
    Konety BR; Metro MJ; Melham MF; Salup RR
    Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors.
    Pode D; Golijanin D; Sherman Y; Lebensart P; Shapiro A
    J Urol; 1998 Feb; 159(2):389-92; discussion 393. PubMed ID: 9649245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
    Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
    Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between cytology and cystoscopy in the follow-up of patients with bladder tumours.
    Dubernard JM; Devonec M; Amiel J; Bouvier R; Fontanière B; Faucon M
    Eur Urol; 1982; 8(1):5-8. PubMed ID: 7060611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of urine cytology for bladder carcinoma diagnosis: comparative study with biopsy].
    Garcia Castro M; Fernández Fernández E; Martín Corriente MC; Garcia Hernández S; Alvarez-Argüelles CH
    Actas Urol Esp; 2008 Oct; 32(9):904-7. PubMed ID: 19044300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer.
    Karnwal A; Venegas R; Shuch B; Bassett J; Rajfer J; Reznichek R
    Can J Urol; 2010 Apr; 17(2):5077-81. PubMed ID: 20398445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and follow-up of superficial bladder tumors using non-invasive techniques].
    Zuloaga Gómez A; Luis Ortiz J; Nogueras Ocaña M; Fernández Mena J; Martínez Torres JL
    Arch Esp Urol; 1990; 43 Suppl 1():21-3. PubMed ID: 2078064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The follow-up of patients with non-muscle-invasive bladder cancer by urine cytology, abdominal ultrasound and urine CYFRA 21-1: a pilot study.
    Nisman B; Yutkin V; Peretz T; Shapiro A; Barak V; Pode D
    Anticancer Res; 2009 Oct; 29(10):4281-5. PubMed ID: 19846987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
    Bergman J; Reznichek RC; Rajfer J
    BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
    Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
    Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine cytology as a screening test for bladder infiltration in cervical cancer.
    Snyman LC; Zondagh BA; Dreyer G; Lindeque BG; Louw M
    Int J Gynecol Cancer; 2006; 16(4):1587-90. PubMed ID: 16884370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy.
    Konety B; Shore N; Kader AK; Porten S; Daneshmand S; Lough T; Lotan Y
    Eur Urol; 2019 Aug; 76(2):238-243. PubMed ID: 31103391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.